Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: A potential early step in drug resistance

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4667-4672

  Panvichian, Ravat ^a   Orth, Kim ^a   Day, Mark L ^a   Day, Kathleen C ^a   Pilat, Mary Josephine ^a   Pienta, Kenneth J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL PROLIFERATION; ENZYME ACTIVATION; HELA CELL; HUMAN; POLYPLOIDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CDC2 PROTEIN KINASE; CELL NUCLEUS; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; HUMANS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0032532689     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rao, S., Krauss, N. E., Heerding, J. M., Swindell, C. S., Ringel, L, Orr, G. A., and Horwitz, S. B. 3′-(p-azidobenzamido) Taxol photolabels the N-terminal 31 amino acids of β-tubulin. J. Biol. Chem., 269: 3132-3134, 1994.
2. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
3. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
4. Rudner, A. D., and Murray, A. W. The spindle assembly checkpoint. Curr. Opin. Cell Biol., 8: 773-780, 1996.
5. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
6. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
7. Salvesen, G. S., and Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell, 91: 443-446,1997.
8. L overexpression inhibits Taxol-induced Yama protease activity and apoptosis. Cell Growth Differ., 7: 1087-1094, 1996.
9. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.), 391: 43-50, 1998.
10. Liu, X., Zou, H., Slaughter, C., and Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89: 175-184, 1997.
11. cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ., 5: 1041-1050, 1994.
12. Bhalla, K., Ibrado, A. M., Tourkina, E., Tang, C., Mahoney, M. E., and Huang, Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia (Baltimore), 7: 563-568, 1993.
13. Liu, Y., Bhalla, K., Hill, C., and Priest, D. G. Evidence for involvement of tyrosine phosphorylation in Taxol-induced apoptosis in a human ovarian tumor cell line. Biochem. Pharmacol., 48: 1265-1272, 1994.
14. Danesi, R., Figg, W. D., Reed, E., and Myers, C. E. Paclitaxel (Taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells. Mol. Pharmacol. 47: 1106-1111, 1995.
15. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 95: 506-526, 1995.
16. Banerjee, S., Fallis, A. G., and Brown, D. L. Differential effects of Taxol on two human cancer cell lines. Oncol. Res., 9: 237-248, 1997.
17. Roberts, J. R., Allison, D. C., Donehower, R. C., and Rowinsky, E. K. Development of polyploidization in Taxol-resistant human leukemic cells in vitro. Cancer Res., 50: 710-716,1990.
18. Panvichian, R., Orth, K., Day, K. C., Day, M., and Pienta, K. J. Paclitaxel-induced multimininucleation is determined by the balance of caspase activators and inhibitors. Proc. Am. Assoc. Cancer Res., 39: 3918a, 1998.
19. Freshney, R. I. Culture of Animal Cells. A Manual of Basic Techniques, 3rd ed., pp. 149-157. New York; John Wiley and Sons, Inc., 1994.
20. Butler. W. B. Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal. Biochem., 141: 70-73, 1984.
21. Martin, S. J., Newmeyer, D. D., Mathias, S., Farschon, D. M., Wang, H. G., Reed, J. C., Kolesnick, R. N., and Green, D. R. Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J., 14: 5191-5200, 1995.
22. Shah, G. M., Poirier, D., Duchaine, C., Brochu, G., Desnoyers, S., Lagueux, J., Verreault, A., Hoflack, J. C., Kirkland, J. B., and Poirier, G. G. Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo. Anal. Biochem., 227: 1-13, 1995.
23. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem., 271: 4573-4576, 1996.
24. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
25. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvessen, G. S., and Dixit, V. M. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
26. Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, K. T., and Nicholson, D. W. A combinatorial approach defines the specificity of members of the caspase family and granzyme B. J. Biol. Chem., 272: 17907-17911,1997.
27. cdc2 activation required for apoptosis. Science (Washington DC). 263: 1143-1145, 1994.
28. Meikrantz, W., and Schlegel, R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem., 271: 10205-10209, 1996.
29. Haldar, S., Jena, N., and Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
30. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
31. Marshall, I. C. B. and Wilson, K. L. Nuclear envelope assembly after mitosis. Trends Cell Biol. 69-74, 1997.
32. Orth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., and Dixit, V. M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem., 271: 16443-16446, 1996.
33. Orth, K., O'Rourke, K., Salvesen, G. S., and Dixit, V. M. Molecular ordering of apoptotic mammalian CED-3/ICE-like protease. J. Biol. Chem., 271: 20977-20980, 1996.
34. Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, G., Moir, R. D., Goldman, R. D., Poirier,G. G., Kaufmann, S. H., and Earnshaw, W. C. Cleavage of lamin A by Mch2α but not CPP32: multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA, 93: 8395-8400, 1996.
35. Kung, A. L., Shrewd, S. W., and Scheme, R. T. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. USA, 87: 9553-9557, 1990.
36. van der Loo, B., Hong, Y., Hancock, V., Martin, J. F., and Erusalimsky, J. D. Antimicrotubule agents induce polyploidization of human leukaemic cell lines with megakaryocytic features. Eur. J. Clin. Invest., 23: 621-629, 1993.
37. Wahl, A. F., Donaldson, K. L., Fairchild, C., Lee, F. Y., Foster, S. A., Demers, G. W., and Galloway, D. A. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat. Med., 2: 72-79, 1996.
38. Debernardis, D., Sire, E. G., De Feudis, P., Vikhanskaya, F., Valenti, M., Russo, P., Parodi, S. D'Incalci, M., and Broggini, M. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res., 57: 870-874, 1997.